Fig. 13From: Identification of DDIT4 as a potential prognostic marker associated with chemotherapeutic and immunotherapeutic response in triple-negative breast cancerSurvival analysis (OS) based on ADM, ENO1, PLOD1, and CEBPB expression in patients with breast cancer obtained from KM plotterBack to article page